Intravesical bacille Calmette-Guérin (BCG) in immunologically compromised patients with bladder cancer Academic Article uri icon

Overview

MeSH Major

  • Adjuvants, Immunologic
  • Antineoplastic Combined Chemotherapy Protocols
  • BCG Vaccine
  • Immunocompromised Host
  • Neoplasm Recurrence, Local
  • Transplants
  • Urinary Bladder Neoplasms

abstract

  • We conclude that intravesical BCG is safe and effective in immunologically compromised patients with bladder cancer. Transplant patients fare worse and should be considered for early cystectomy if they fail BCG therapy.

publication date

  • May 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1464-410X.2012.11778.x

PubMed ID

  • 23351086

Additional Document Info

start page

  • 984

end page

  • 7

volume

  • 111

number

  • 6